// App-Quantinova.ai

9044 : Exome analysis to reveal genomic markers associated with better efficacy of nivolumab in lung cancer patients.

Researchers

Presenter

  • Corentin Richard

Principal Investigators

  • Jean-David Fumet

  • Sandy Chevrier

  • Valentin Derangere

  • Fanny Ledys

  • Aurelie Lagrange

  • Laure Favier

  • Bruno P. Coudert

  • Laurent Arnould

  • Caroline Truntzer

  • Romain Boidot

  • Fran Aois Ghiringhelli

Medical Centers

  • Research Platform in Biological Oncology, Center GF Leclerc, Dijon, France

  • Department of Medical Oncology, Center GF Leclerc, Dijon, France

  • Research Platform in Biological Oncology, Dijon, France

  • Department of Medical Oncology, Center GF Leclerc, Dijon, France

  • Department of Medical Oncology, Center GF Leclerc, Dijon, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Mitogen-activated protein kinase

  • T-cell receptor

  • Tumor mutational burden

Drug/Treatment

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved